OVERWEIGHT/OBESITY Clinical Trials

130 clinical trials for OVERWEIGHT/OBESITY across international registries, including 54 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Effect of Probiotics on Appetite Regulation in Adults With Overweight/Obesity — RECRUITING · NA
• Efficacy and Safety of Akkermansia Muciniphila AKM Lab-01 for Overweight and Obesity — RECRUITING · NA
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE-MONTHLY PF-08653944 IN ADULTS WITH OVERWEIGHT OR OBESITY {VESPER 6) — RECRUITING · PHASE3
• ASSESSMENT OF THE NATURAL HISTORY AND PROGNOSTIC FACTORS OF THERAPEUTIC RESPONSE IN SUB-PHENOTYPES OF PATIENTS WITH OBESITY: THE BOLOBE STUDY — RECRUITING
• Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants — RECRUITING · PHASE1
• SucroMet Nutritional Intervention Trial — RECRUITING · NA
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults — RECRUITING · PHASE1
• A PHASE II, RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, 42-WEEK DOSE-FINDING TRIAL FOR BI 3034701 ADMINISTERED SUBCUTANEOUSLY COMPARED TO PLACEBO IN PARTICIPANTS WITH OBESITY OR OVERWEIGHT — RECRUITING · PHASE2
• Smartwatch-based Intervention for Cardiovascular Health (SWITCH) — RECRUITING · NA
• A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER MASTER PROTOCOL TO EVALUATE THE EFFICACY AND SAFETY OF ELECOGLIPRON IN PARTICIPANTS WITH OBESITY OR OVERWEIGHT WITH OR WITHOUT TYPE 2 DIABETES MELLITUS (EMBOLD) — RECRUITING · PHASE3
• BfedBwell INSPIRE Pilot — RECRUITING · NA
• A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants — RECRUITING · PHASE1
• MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity — RECRUITING · PHASE2
• Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program — RECRUITING · NA
• Snacking Effects on the Brain Response to Foods and Satiety During Dieting — RECRUITING · NA
• Effects of Cranberry on Gut and Metabolic Health — RECRUITING · NA
• A MASTER PROTOCOL FOR PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE WEEKLY ELORALINTIDE IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNEA, AND OBESITY OR OVERWEIGHT (ENLIGHTEN-3) — RECRUITING · PHASE3
• High Phenolic Olive Oil for Enhancing Metabolic Health: a Randomized-controlled Trial in Patients With cEntral Obesity (HOPE) — RECRUITING · NA
• A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-WEEKLY RO7795068 ADMINISTERED TO PARTICIPANTS WITH OBESITY OR OVERWEIGHT WITHOUT TYPE 2 DIABETES — RECRUITING · PHASE3
• A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-WEEKLY RO7795068 ADMINISTERED TO PARTICIPANTS WITH OBESITY OR OVERWEIGHT AND TYPE 2 DIABETES — RECRUITING · PHASE3
• EFFICACY AND SAFETY OF NNC0487-0111 S.C. ONCE-WEEKLY IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY, AND KNEE OSTEOARTHRITIS (AMAZE 5) — RECRUITING
• Bioequivalence Study of BGM0504 Injection — RECRUITING · PHASE1
• EVALUATING THE EFFICACY AND SAFETY OF MET097, A FULLY-BIASED, ULTRA LONG-ACTING GLP-1RA, IN PEOPLE WITH OVERWEIGHT OR OBESITY: A PHASE 3, MULTI-CENTER RANDOMIZED, CONTROLLED TRIAL (VESPER-4) — RECRUITING · PHASE3
• EVALUATING THE EFFICACY AND SAFETY OF MET097, A FULLY-BIASED, ULTRA LONG-ACTING GLP-1RA, IN PEOPLE WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES: A PHASE 3, MULTI-CENTER RANDOMIZED, PLACEBO-CONTROLLED TRIAL (VESPER-5) — RECRUITING · PHASE3
• Asiaticoside for Treating Overweight/Obesity — RECRUITING · NA
• A RANDOMIZED, DOUBLE-BLIND SINGLE ASCENDING DOSE STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MET-815 ADMINISTERED ALONE, AND FOLLOWING MET097 LEAD-IN TREATMENT, IN OTHERWISE HEALTHY ADULT PARTICIPANTS WITH OBESITY OR OVERWEIGHT. — RECRUITING
• Immediate Effect of Whole-Body Vibration on Cardiovascular Response and Functional Capacity in Overweight/Obese Young Women — RECRUITING · NA
• A PHASE 3B STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DIFFERENT RETATRUTIDE DOSE ESCALATION SCHEMES IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR OVERWEIGHT: A RANDOMIZED, CONTROLLED, DOUBLE-BLIND TRIAL (TRIUMPH-9) — RECRUITING · PHASE3
• A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MARIDEBART CAFRAGLUTIDE IN ADULT PARTICIPANTS WITH OBSTRUCTIVE SLEEP APNEA NOT ON POSITIVE AIRWAY PRESSURE THERAPY AND LIVING WITH OVERWEIGHT OR OBESITY (MARITIME-OSA-2) — RECRUITING · PHASE3
• WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study — RECRUITING · NA
• A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MET034 ALONE AND ADMINISTERED WITH MET097 IN ADULT PARTICIPANTS WITH OBESITY OR OVERWEIGHT BUT OTHERWISE HEALTHY — RECRUITING · PHASE1
• EFFICACY AND SAFETY OF CAGRILINTIDE FOR WEIGHT MANAGEMENT IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES (RENEW 2) — RECRUITING
• EFFICACY AND SAFETY OF CAGRILINTIDE FOR WEIGHT MANAGEMENT IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY (RENEW 1) — RECRUITING
• A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE IMPACT OF MARIDEBART CAFRAGLUTIDE ON CARDIOVASCULAR OUTCOMES IN PARTICIPANTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OVERWEIGHT OR OBESITY (MARITIME-CV) — RECRUITING · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER PHASE 2 STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ONCE-WEEKLY CT-388 ADMINISTERED SUBCUTANEOUSLY FOR 48 WEEKS TO PARTICIPANTS WHO ARE OVERWEIGHT OR OBESE WITH TYPE 2 DIABETES MELLITUS — RECRUITING · PHASE2
• A PHASE 3B, RANDOMIZED, MULTICENTER, CONTROLLED STUDY OF MIRIKIZUMAB AND PLACEBO OR MIRIKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS AND OBESITY OR OVERWEIGHT — RECRUITING · PHASE3
• A PHASE 3B, RANDOMIZED, MULTICENTER, CONTROLLED STUDY OF MIRIKIZUMAB AND PLACEBO OR MIRIKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE CROHN¿S DISEASE AND OBESITY OR OVERWEIGHT — RECRUITING · PHASE3
• tVNS and Obesity-related Mechanisms — RECRUITING · NA
• A PHASE 2B DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF BIMAGRUMAB AND TIRZEPATIDE, ALONE OR IN COMBINATION, TO INVESTIGATE THE EFFICACY AND SAFETY IN ADULT PARTICIPANTS WITH OBESITY OR OVERWEIGHT WITH TYPE 2 DIABETES — RECRUITING · PHASE2
• A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLELGROUP STUDY EVALUATING THE EFFICACY AND LONG-TERM SAFETY OF TIRZEPATIDE ONCE WEEKLY COMPARED TO PLACEBO IN ADULTS WITH TYPE 1 DIABETES AND OBESITY OR OVERWEIGHT (SURPASS-T1D-2) — RECRUITING · PHASE3
• Effect of Low Valine Diet on Body Weight and Metabolic Parameters — RECRUITING · NA
• A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MARIDEBART CAFRAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE OBESITY OR ARE OVERWEIGHT (MARITIME 2) — RECRUITING · PHASE3
• A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO¿CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MARIDEBART CAFRAGLUTIDE IN ADULT PARTICIPANTS WITHOUT TYPE 2 DIABETES MELLITUS WHO HAVE OBESITY OR ARE OVERWEIGHT (MARITIME-1) — RECRUITING · PHASE3
• Functional Cereal Products and Contribution to the Regulation of Metabolism and Obesity-induced Chronic Low-grade Inflammation. — RECRUITING · NA
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RETATRUTIDE ONCE WEEKLY IN PARTICIPANTS WHO HAVE OBESITY OR OVERWEIGHT AND CHRONIC LOW BACK PAIN (TRIUMPH-7) — RECRUITING · PHASE3
• A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE-RANGING STUDY OF PF-07976016 TO ASSESS SAFETY AND EFFICACY IN ADULT PARTICIPANTS WITH OBESITY. — RECRUITING · PHASE2
• EFFICACY AND SAFETY OF CAGRILINTIDE S.C. IN COMBINATION WITH SEMAGLUTIDE S.C.(CAGRISEMA S.C. 1.0 MG/1.0 MG AND 1.7 MG/1.7 MG) ONCE-WEEKLY IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY — RECRUITING
• Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism — RECRUITING · PHASE4
• A MASTER PROTOCOL TO INVESTIGATE THE EFFICACY AND SAFETY OF LY3437943 ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR OVERWEIGHT: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (TRIUMPH-1) — RECRUITING
• EFFICACY AND SAFETY OF ORAL SEMAGLUTIDE 25 MG ONCE DAILY IN ADULTS WITH OVERWEIGHT OR OBESITY (OASIS 4) — RECRUITING

Refine this search